Top 10 Pharma CEO salaries of 2009

Welcome to to our annual look at the biggest CEO paychecks in the pharma industry. The major trend  in 2009 was the mega-merger, which helped propel former Schering-Plough CEO Fred Hassan to the top of this year's list. With the help of a $33 million golden handshake, Hassan bypassed perennial top dogs Bill Weldon (Johnson & Johnson) and Miles White (Abbott) as the highest-paid CEO in Pharma.

Novartis' Daniel Vasella moved up three places to the number four spot this year, but it will be his last appearance on our CEO pay list. Vasella stepped down as chief of Novartis in January, and was replaced by Joe Jimenez. To discover more details for yourself--or to find out what your boss is making--take a look at the list below.

1. Fred Hassan - Schering-Plough - $49.65M

2. Bill Weldon - Johnson & Johnson - $30M

3. Miles White - Abbott Laboratories - $26.2M

4. John Lechleiter - Eli Lilly - $20.9M

5. Daniel Vasella - Novartis - $20.24M

6. Jim Cornelius - Bristol-Myers Squibb - $18.2M

7. Richard Clark - Merck - $16.8M

8. Robert Coury - Mylan - $16M

9. Jeffrey Kindler - Pfizer - $14.8M

10. Frank Baldino - Cephalon - $11.1M

Top 10 Pharma CEO salaries of 2009

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.